Novel Targets for Drug Development: Oncology, Gynecology, Cardiology, Hematology

Sponsor Deadline: 

Mar 31, 2018

Sponsor: 

Bayer Grants4Targets Pharmaceuticals

UI Contact: 

Bayer Grants4Targets Pharmaceuticals 
https://grants4targets.bayer.com/home/pharma/

Target must be a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug (drug can be a small-molecular-weight chemical compound or a biological, such as an antibody or a recombinant protein).  Target should have shown to be effective/mechanistically involved in the disease by relevant in vitro or in vivo models.  Target is disease-modifying and/or has a proven function in the pathophysiology of a disease.

Oncology
Gynecology
Heart & Vascular Diseases
Specialty Lung Diseases
Kidney Diseases
Hemostatic & Acute Organ Disorders

Categories: 

Keywords: